Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity

Daniel S. Leventhal(Synlogic (United States)), José M. Lora(Hospital for Special Surgery)
Nature Communications
June 1, 2020
Cited by 426


Related Papers

No related papers found

Powered by citation graph analysis